8-June-2010
English
The key goal of the current work is to identify further means (e.g. international guidelines, policy recommendations) to implement the 2004 OECD Science and Technology Ministers mandate on “Biotechnology for Sustainable Growth and Development” .
28-April-2010
English
This document compiles the operational plans 2009-2012 for the eight projects of the WPMN and it is published on the responsibility of the Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology of the OECD.
11-March-2010
English
Workshop discussions were structured around a set of issues papers – one for each of the sessions. The workshop was set up as a working roundtable discussion. 50 participants familiar with data sources for industrial biotechnology attended the workshop.
15-September-2009
English
This workshop brought together policy makers, economists, and business representatives to share their views and experience in fostering demand for innovation via market and public policy instruments including public procurement, pricing, regulations, standards-setting and lead markets.
7-August-2009
English
The workshop discussed existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.
9-July-2009
English
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms.
17-March-2009
English
Speech by OECD Deputy Secretary-General Pier Carlo Padoan at the INCOM Workshop on Innovation and Growth Policy in the EU, Prague, 22-23 January 2009
24-February-2009
English, , 50kb
Summary and conclusions of a seminar held at the OECD on 16 February 2009.
28-January-2009
English
This workshop will examine ways in which knowledge contributes to innovation, especially in developing countries.
30-October-2008
English
The impact of biotechnologies on medical research is intensifying. Because of new highly performing technologies, we are better able to understand and explore disease and drug mechanisms, which in turn could lead to major changes in the approach of patient care.